HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of patch formulation of tulobuterol, a long-acting beta2-adrenoreceptor agonist, in the treatment of severe pediatric asthma.

AuthorsShigemi Yoshihara, Yumi Yamada, Toshio Abe, Osamu Arisaka
JournalAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology (Ann Allergy Asthma Immunol) Vol. 96 Issue 6 Pg. 879-80 (Jun 2006) ISSN: 1081-1206 [Print] United States
PMID16802779 (Publication Type: Letter, Randomized Controlled Trial)
Chemical References
  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists
  • Bronchodilator Agents
  • tulobuterol
  • Beclomethasone
  • Terbutaline
Topics
  • Administration, Cutaneous
  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists (administration & dosage, therapeutic use)
  • Asthma (drug therapy)
  • Beclomethasone (administration & dosage, therapeutic use)
  • Bronchodilator Agents (administration & dosage, therapeutic use)
  • Child
  • Drug Therapy, Combination
  • Humans
  • Peak Expiratory Flow Rate (drug effects)
  • Terbutaline (administration & dosage, analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: